ADVFN - ニュース

US Dollar vs Yen

登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

登録

銘柄名/コード:

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/24	06 : 02	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:MCK	McKesson Corporation
2024/05/24	06 : 02	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:XEL	Xcel Energy Inc
2024/05/24	06 : 02	Business Wire	KBRA Assigns AAA Rating, Stable Outlook to the New Mexico Finance Authority State Transportation Revenue Refunding Bonds (State Transportation Commission - Senior Lien), Series 2024A
2024/05/24	06 : 01	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:MCK	McKesson Corporation
2024/05/24	06 : 01	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	NYSE:BAC	Bank of America Corporation
2024/05/24	06 : 01	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:MCK	McKesson Corporation
2024/05/24	06 : 01	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:NSP	Insperity Inc
2024/05/24	06 : 01	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	NYSE:BMO	Bank of Montreal
2024/05/24	06 : 01	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:MCK	McKesson Corporation
2024/05/24	06 : 01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:STEL	Stellar Bancorp Inc
2024/05/24	06 : 01	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:CINGW	Cingulate Inc
2024/05/24	06 : 01	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:WEAV	Weave Communications Inc
2024/05/24	06 : 01	Business Wire	NMDP and CIBMTR to Present New, Promising Stem Cell Transplantation Trial Data using Mismatched, Unrelated Donors at 2024 ASCO Annual Meeting
2024/05/24	06 : 01	Business Wire	Verastem Oncology Announces Positive Initial Interim Safety and Efficacy Results from RAMP 205 Trial Evaluating Avutometinib Plus Defactinib in Combination with Gemcitabine and Nab-paclitaxel in First-Line Metastatic Pancreatic Cancer	NASDAQ:VSTM	Verastem Inc
2024/05/24	06 : 00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:CRM	Salesforce Inc
2024/05/24	06 : 00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:MCK	McKesson Corporation
2024/05/24	06 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:KNTK	Kinetik Holdings Inc
2024/05/24	06 : 00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AGYS	Agilysys Inc
2024/05/24	06 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:YUMC	Yum China Holdings Inc
2024/05/24	06 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MEDS	TRxADE HEALTH Inc
2024/05/24	06 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:EQ	Equillium Inc
2024/05/24	06 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ABVC	ABVC BioPharma Inc
2024/05/24	06 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:RZC	Reinsurance Group of America Incorporated
2024/05/24	06 : 00	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:LILMW	Lilium NV
2024/05/24	06 : 00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:EOG	EOG Resources Inc
2024/05/24	06 : 00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:FMSTW	Foremost Lithium Resource and Technology Ltd
2024/05/24	06 : 00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:LEGN	Legend Biotech Corporation
2024/05/24	06 : 00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CURIW	CuriosityStream Inc
2024/05/24	06 : 00	Business Wire	Genmab to Showcase Data in Various Patient Populations to be Presented at the American Society of Clinical Oncology (ASCO) Annual Meeting	NASDAQ:GMAB	Genmab AS
2024/05/24	06 : 00	Business Wire	Merck to Showcase Advances in the Science of Cancer With New Data Presented at ASCO 2024

1 2 3 4 5 6 7 8 9 10 次へ >>

NLBNPIT1Z6F8 20991231 14...

Vitesco Technologies (PK)

NLBNPIT1ZJ10 20240918 46...

NLBNPIT20WH0 20240920 38

NLBNPIT20A83 20240918 21...

TD Canadian Aggregate Bo...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約